Company / Current Liabilities per Share
Unicycive Therapeutics, Inc. Current Liabilities per Share History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.69
FY2024
5-year range
$0.22 / $1.15
FY2022-FY2024
Trend
-39.7%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $0.22 to $0.69 over the past 2 years.
Based on SEC 10-K filings.
0.69 in FY2024.
Increased from $0.22 to $0.69 over the past 2 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, current liabilities per share decreased 39.7% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.91 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.69 | -39.7% |
| FY2023 | $1.15 | +425.7% |
| FY2022 | $0.22 | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026